Alector to participate in upcoming healthcare conferences

South san francisco, calif., feb. 25, 2025 (globe newswire) -- alector, inc. (nasdaq: alec), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in the following upcoming investor conferences:
ALEC Ratings Summary
ALEC Quant Ranking